BUPROPION XR Sandoz cpr ret 300 mg 30 pce
7680686280038
CH-68628
N06AX12
01.06.0.
Reimbursement limitations:
WELLBUTRIN X
Traitement des épisodes dépressifs;
la thérapie doit être débutée par un psychiatre ou neurologue.
1 / 3
google
Details
- Product number
- 6862802
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- bupropioni hydrochloridum 300 mg, povidonum K 90, cysteini hydrochloridum monohydricum, silica colloidalis anhydrica, glyceroli dibehenas, magnesii stearas, Überzug: ethylcellulosum, povidonum K 90, macrogolum 1450, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas corresp. natrium 0.005 mg, polysorbatum 80, silica colloidalis hydrica, triethylis citras, Drucktinte: lacca, E 172 (nigrum), alcohol butylicus, propylenglycolum, ammoniae solutio 28 per centum, pro compresso obducto.
Articles (1)
Bupropion XR Sandoz 300 mg, Retardtabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
0.005 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 39.30
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/12/2024
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 68628
- Drug name
- Bupropion XR Sandoz, Retardtabletten
- Galenic form
- RETT
- ATC Code
- N06AX12
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 12/12/2023
- Authorization expiration date
- 11/12/2028
- IT number
- 01.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BUPROPION XR Sandoz cpr ret 300 mg 30 pce
- Description (DE)
- BUPROPION XR Sandoz Ret Tabl 300 mg 30 Stk
- Market launch
- 12/12/2023
- Narcotic (BTM)
- No